摘要
由于外科技术和围手术期处理手段的改进,胰腺癌手术切除的疗效已获较大提高。目前,在世界各地大型综合医院中其手术死亡率及并发症发生率均大幅降低,但术后长期生存率迄今仍未得到很好改善。2000年中国抗癌协会胰腺癌专业委员会14家大型医院的2340例根治性手术统计结果表明,胰腺癌根治术后中位生存期为17.1个月,5年生存率仅为8.47。
出处
《外科理论与实践》
2009年第1期118-122,共5页
Journal of Surgery Concepts & Practice
参考文献35
-
1Zhang QH, Ni QX; Coordination Group of The Committee on Pancreatic Cancer. Clinical analysis of 2340 cases of pancreatic cancer [J]. Zhonghua Yi Xue Za Zhi,2004,84 (3):214-218.
-
2Matsuno S, Egawa S, Fukuyama S, et al. Pancreatic Cancer Registry in Japan: 20 years of experience[J]. Pancreas,2004,28(3):219-230.
-
3Sohn TA, Yeo C J, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators [J]. J Gastrointest Surg,2000,4 (6):567-579.
-
4Cleary SP, Gryfe R, Guindi M, et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5- year survivors[J]. J Am Coll Surg,2004,198(5):722-731.
-
5Richter A, Niedergethmann M, Sturm JW, et al. Long- term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience[J]. World J Surg,2003,27(3):324-329.
-
6Sperti C, Pasquali C, Piccoli A, et al. Recurrence after resection for ductal adenocarcinoma of the pancreas [J]. World J Surg, 1997,21 (2): 195-200.
-
7Farnell MB, Pearson RK, Sarr MG, et al. A prospective randomized trial comparing standard pancreatoduodenec-omy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma[J]. Surgery,2005,138(4):618-628.
-
8Bakkevold KE, Arnesjφ B, Dahl O, et al. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater-resuhs of a controlled, prospective, randomised multieentre study [J]. Eur J Cancer,1993,29A(5):698-703.
-
9Takada T, Amano H, Yasuda H, et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase Ⅲ multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma[J]. Cancer,2002,95(8): 1685-1695.
-
10Kosuge T, Kiuchi T, Mukai K, et al. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer [J]. Jpn J Clin Oncol, 2006,36(3): 159-165.
同被引文献5
-
1楼文晖.根治性胰腺癌切除术后吉西他滨辅助化疗的随机对照临床研究[J].中华医学杂志,2007,87(22):1544-1544. 被引量:2
-
2Beger HG, Gansauge F, Buchler MW, et al. Intraarterial adjuvant chemotherapy after panereatieeduedenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis[ J]. World J Surg, 1999,23 (9) :946- 949.
-
3Papachristou E, Link KH, Schoenberg MH. Regional celiac artery infusion in the adjuvant treatment of pancreatic cancer[J]. Anticancer Res ,2003,23 (2A) :831 - 834.
-
4景钊,南克俊,张晓战,阮之平,郭卉,徐瑞.晚期胰腺癌全身化疗的疗效观察[J].癌症,2004,23(4):439-442. 被引量:17
-
5徐近,倪泉兴,傅德良,金忱,虞先浚,龙江,张延龄.胰腺癌术后介入化疗作用的探讨[J].中国实用外科杂志,2004,24(5):285-287. 被引量:19
二级引证文献3
-
1李建良.氟尿嘧啶联合肝复乐治疗晚期胰腺癌的临床研究[J].当代医学,2012,18(35):136-137.
-
2李文文,闫涵,曹邦伟.胰腺癌术后辅助化疗远期疗效:系统综述和meta分析[J].医学临床研究,2016,33(4):637-641. 被引量:3
-
3田龙夫,崔云峰,马波,陈旭红.胰腺癌根治术后联合化疗药物治疗对患者生存期的影响:系统评价和Meta分析[J].湖北民族学院学报(医学版),2017,34(4):31-35. 被引量:2
-
1金辉,李恩全,马钦波.胰腺癌根治术后胰瘘的防治[J].云南医药,1999,20(3):197-198. 被引量:1
-
2赵玉沛,刘伯南,张太平.努力提高我国胰腺癌外科诊治水平[J].中华普外科手术学杂志(电子版),2009,3(1):1-3. 被引量:9
-
3景在平.胰腺癌外科治疗的演进和回顾[J].临床医学,1989,9(1):33-34. 被引量:1
-
4张维建,韩少良,蒋飞照,朱恒梁,叶百亮,柯庆宏,方瑶.胰腺癌根治切除术后远期疗效的多因素分析[J].中华肿瘤杂志,2008,30(11):870-872. 被引量:6
-
5高芳,苏宁.癌性腹水的辨治[J].中国中医急症,2011,20(12):1952-1952. 被引量:12
-
6吴伟.胃间质瘤的外科治疗(附40例报告)[J].实用临床医药杂志,2008,12(4):71-73. 被引量:8
-
7卢震海,万德森.胃肠道间质瘤的外科治疗[J].广东医学,2004,25(3):233-235. 被引量:26
-
8苏丹,白莉.283例胰腺癌根治术后患者临床资料和生存分析[J].实用肿瘤杂志,2016,31(6):526-530. 被引量:8
-
9刘自明,严律南,李馨筱.胰腺癌患者行胰十二指肠切除术后长期生存率的影响因素[J].华西医学,2007,22(4):740-741. 被引量:1
-
10陆晓哲,王安喜,卓文利,管玉斌.术前化疗对儿童肾母细胞瘤手术疗效的影响[J].人民军医,2008,51(10):650-651. 被引量:1